MayMag Biologics, formerly Tirzepatide Pharma, is a leading FDA-registered biologics manufacturer and a prominent EpiPen insulin biosimilar injector pen manufacturer, specializing in the large-scale production of FDA shortlist drugs for global distribution.

Large-Scale Manufacturing for Rheumatoid Arthritis Pen Medications

As a premier auto-injector pen contract manufacturer, MayMag Biologics provides comprehensive CDMO and CMO services for complex sterile therapeutics. We specialize in the high-volume production of sterile rheumatoid arthritis pen medications, offering end-to-end manufacturing solutions from formulation to sterile fill-finish and final device assembly.

Our state-of-the-art facilities are designed to support major pharmaceutical firms in bringing critical therapies to market at scale. By partnering with MayMag Biologics, you gain access to a dedicated rheumatoid arthritis auto-injection manufacturer equipped with the infrastructure and regulatory expertise to meet global commercial demand.

Supporting FDA Short-Listed Sterile Generics

MayMag Biologics is committed to stabilizing the global pharmaceutical supply chain. Operating as a responsive FDA drug shortage manufacturer, we actively partner with firms to produce and scale FDA short-listed sterile generics. Our agile production lines are optimized to rapidly address market deficits, ensuring that essential anti-inflammatory and arthritis medications consistently reach the healthcare systems and patients who depend on them.

Core CDMO & CMO Capabilities

Integrated Device Assembly: As a specialized sterile contract manufacturer, we seamlessly integrate advanced sterile fill-finish processes with precise auto-injector pen assembly, ensuring patient-ready, easy-to-use delivery systems.

High-Volume Production: Functioning as a high-volume sterile CDMO, we offer the robust capacity required to manufacture millions of pen units annually while maintaining uncompromising adherence to cGMP quality standards.

Reliable Generic Supply: Whether you are seeking a sterile injectables generic manufacturer to produce off-patent biologics or need a reliable partner to secure your current supply chain, our exclusive B2B model delivers efficiency and scale.

Full Product Portfolio

MayMag Biologics is a USA-based large-scale industrial supplier of:

• Auto-pen medications
• Diabetic insulin 70/30 pens and glargine
• Biosimilars
• Nasal sprays
• EpiPens and epinephrine auto-injectors
• Weight loss treatments (GLP-1/GIP agonists)
• Bacteriostatic water for injection (Bac Water)
• Ophthalmology products

Establish a Professional Partnership

Contact MayMag Biologics to discuss your CDMO or CMO requirements. As an FDA-registered 506(e) CDMO/IND facility, we are ready to support your manufacturing needs at any scale.